Philip N Ainslie Selected Research

Gases

4/2017	Adenosine receptor-dependent signaling is not obligatory for normobaric and hypobaric hypoxia-induced cerebral vasodilation in humans.
1/2017	One session of remote ischemic preconditioning does not improve vascular function in acute normobaric and chronic hypobaric hypoxia.
11/2015	Peripheral chemoreflex inhibition with low-dose dopamine: new insight into mechanisms of extreme apnea.
1/2015	Regulation of brain blood flow and oxygen delivery in elite breath-hold divers.
3/2012	Effects of acetazolamide on cerebrovascular function and breathing stability at 5050 m.
4/2011	Influence of indomethacin on the ventilatory and cerebrovascular responsiveness to hypoxia.
5/2007	Morning attenuation in cerebrovascular CO2 reactivity in healthy humans is associated with a lowered cerebral oxygenation and an augmented ventilatory response to CO2.
5/2007	Cardiorespiratory and cerebrovascular responses to acute poikilocapnic hypoxia following intermittent and continuous exposure to hypoxia in humans.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Philip N Ainslie Research Topics

Disease

52	Hypoxia (Hypoxemia) 07/2022 - 07/2004
14	Hypercapnia 11/2021 - 05/2007
12	Apnea 01/2022 - 05/2007
11	Hypocapnia 01/2021 - 07/2008
9	Syncope (Fainting) 08/2015 - 07/2008
7	Hypotension (Low Blood Pressure) 11/2021 - 01/2010
7	Hyperventilation 01/2020 - 11/2009
6	Hypertension (High Blood Pressure) 01/2022 - 08/2010
6	Hyperoxia 10/2021 - 03/2014
5	Altitude Sickness (Mountain Sickness) 01/2022 - 06/2014
5	Polycythemia (Erythrocytosis) 01/2022 - 03/2016
5	Inflammation (Inflammations) 01/2021 - 12/2004
5	Spinal Cord Injuries (Spinal Cord Injury) 01/2019 - 03/2014
4	Hyperthermia 01/2021 - 07/2015
3	Acidosis 01/2022 - 02/2015
3	Chronic Obstructive Pulmonary Disease (COPD) 12/2021 - 01/2018
3	Stroke (Strokes) 01/2019 - 11/2013
3	Central Sleep Apnea (Central Sleep Apnea Syndrome) 01/2018 - 10/2014
3	Intracranial Hypertension 01/2018 - 08/2012
2	Respiratory Acidosis 01/2022 - 12/2021
2	Respiratory Alkalosis 01/2022 - 01/2020
2	Alkalosis 12/2021 - 01/2021
2	Obesity 11/2021 - 12/2019
2	Body Weight (Weight, Body) 12/2019 - 08/2012
2	Fatigue 01/2018 - 01/2005
2	Reperfusion Injury 01/2018 - 01/2017
2	Anemia 01/2017 - 03/2016
1	Neurodegenerative Diseases (Neurodegenerative Disease) 07/2022
1	Parkinson Disease (Parkinson's Disease) 07/2022
1	Patent Foramen Ovale 07/2022
1	Vascular Remodeling 01/2022
1	Diabetic Ketoacidosis (Ketoacidosis, Diabetic) 12/2021
1	Cognitive Dysfunction 11/2021
1	Dementia (Dementias) 11/2020
1	Immersion Foot (Trench Foot) 10/2020
1	Heart Arrest (Cardiac Arrest) 10/2020
1	Brain Hypoxia (Cerebral Hypoxia) 01/2020
1	Brain Injuries (Brain Injury) 01/2020
1	Ketosis 12/2019
1	Hyperemia 11/2019
1	Headache (Headaches) 03/2019
1	Glucose Intolerance 02/2019
1	Hyperglycemia 02/2019

Drug/Important Bio-Agent (IBA)

31	Oxygen (Dioxygen)IBA 01/2022 - 02/2007
15	Carbon DioxideIBA 01/2022 - 07/2004
8	GasesIBA 04/2017 - 05/2007
8	Indomethacin (Indometacin)FDA LinkGeneric 01/2016 - 04/2011
7	4-S-(propionic acid)sulfidocyclophosphamide (PASP)IBA 01/2022 - 03/2014
5	Adrenergic Agents (Adrenergic Drugs)IBA 01/2022 - 01/2010
5	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2021 - 03/2016
4	AcidsIBA 12/2021 - 02/2015
4	Glucose (Dextrose)FDA LinkGeneric 12/2019 - 12/2004
4	Dihydrotachysterol (AT 10)IBA 04/2017 - 10/2008
4	Nitroprusside (Sodium Nitroprusside)FDA LinkGeneric 06/2013 - 08/2010
3	IronIBA 01/2022 - 01/2018
3	Bicarbonates (Hydrogen Carbonate)IBA 01/2022 - 01/2021
3	Acetazolamide (Diamox)FDA LinkGeneric 01/2021 - 10/2014
3	Free RadicalsIBA 01/2021 - 01/2018
3	2- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA 12/2020 - 12/2017
3	Biomarkers (Surrogate Marker)IBA 01/2020 - 01/2017
3	Hemoglobins (Hemoglobin)IBA 11/2019 - 01/2019
3	esmolol (Brevibloc)FDA LinkGeneric 01/2019 - 04/2017
3	Adenosine (Adenocard)FDA LinkGeneric 04/2017 - 02/2010
3	Phenylephrine (Neo-Synephrine)FDA LinkGeneric 05/2013 - 08/2010
2	KetonesIBA 11/2021 - 12/2019
2	Sodium Bicarbonate (Baking Soda)FDA LinkGeneric 01/2021 - 01/2021
2	salicylhydroxamic acid (SHAM)IBA 01/2020 - 03/2019
2	BuffersIBA 01/2019 - 01/2018
2	AntioxidantsIBA 01/2018 - 12/2004
2	Pharmaceutical PreparationsIBA 01/2018 - 01/2016
2	Lactic Acid (Lactate)FDA LinkGeneric 09/2017 - 05/2014
2	Midodrine (Midon)FDA LinkGeneric 05/2014 - 03/2014
2	Insulin (Novolin)FDA Link 06/2008 - 12/2004
1	Glial Fibrillary Acidic ProteinIBA 01/2022
1	UbiquitinIBA 01/2022
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 11/2021
1	Superoxides (Superoxide)IBA 01/2021
1	NADPH Oxidases (NAD(P)H oxidase)IBA 01/2021
1	Chelating AgentsIBA 01/2021
1	Xanthine OxidaseIBA 01/2021
1	tau Proteins (tau Protein)IBA 01/2021
1	hydroxide ionIBA 01/2021
1	Sucrose (Saccharose)IBA 01/2021
1	Deferoxamine (Desferal)FDA LinkGeneric 01/2021
1	Carnitine O-Palmitoyltransferase (Carnitine Palmitoyltransferase II)IBA 10/2020
1	Tissue Plasminogen Activator (Alteplase)FDA Link 01/2020
1	Nitric Oxide Synthase (NO Synthase)IBA 01/2020
1	Reactive Oxygen Species (Oxygen Radicals)IBA 12/2019
1	3-Hydroxybutyric Acid (beta-Hydroxybutyric Acid)IBA 12/2019

Therapy/Procedure

6	Lower Body Negative Pressure 08/2015 - 08/2009
4	Controlled Hypotension 04/2017 - 07/2008
3	Therapeutics 07/2022 - 01/2018
3	Lasers (Laser) 01/2021 - 02/2017
2	Hemodilution 10/2021 - 03/2016
1	Catheters 07/2022
1	Microbubbles 07/2022
1	Resistance Training 11/2021
1	Endurance Training 11/2021
1	Steam Bath (Sauna) 01/2021
1	Resuscitation 10/2020